Compare WVE & SPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WVE | SPFI |
|---|---|---|
| Founded | 2012 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 744.8M | 812.0M |
| IPO Year | 2015 | 2019 |
| Metric | WVE | SPFI |
|---|---|---|
| Price | $3.88 | $42.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 4 |
| Target Price | $18.53 | ★ $50.75 |
| AVG Volume (30 Days) | ★ 2.8M | 89.4K |
| Earning Date | 11-09-2026 | 10-22-2026 |
| Dividend Yield | N/A | ★ 1.73% |
| EPS Growth | N/A | ★ 17.81 |
| EPS | N/A | ★ 1.82 |
| Revenue | ★ $3,704,000.00 | N/A |
| Revenue This Year | $20.53 | $17.14 |
| Revenue Next Year | N/A | $9.15 |
| P/E Ratio | ★ N/A | $23.07 |
| Revenue Growth | ★ 149.43 | N/A |
| 52 Week Low | $3.56 | $35.34 |
| 52 Week High | $21.73 | $46.94 |
| Indicator | WVE | SPFI |
|---|---|---|
| Relative Strength Index (RSI) | 36.57 | N/A |
| Support Level | N/A | N/A |
| Resistance Level | $6.33 | N/A |
| Average True Range (ATR) | 0.21 | 0.00 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 38.99 | 0.00 |
WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
South Plains Financial Inc operates as a bank holding company. The company provides a wide range of commercial and consumer financial services to small and medium-sized businesses and individuals. The principal business activities include commercial and retail banking, along with insurance, investment, trust, and mortgage services. The company has one reportable segment: banking. The majority of the company's revenues is derived from interest income and other sources, including loans, securities and derivatives.